1 Stradling JR, Crosby JH. Predictors and prevalence of obstructive sleep apnoea and snoring in 1001 middle aged men. Thorax 1991;46:85-90.

2 Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Eng J Med 1993;328:1230-5.

3 Bearpark H, Elliott L, Grunstein R, Cullen S, Schneider H, Althaus W, et al. Snoring and sleep apnea. A population study in Australian men. Am J Respir Crit Care Med 1995:151:1459-65.

4 Jennum P, Sjol A. Epidemiology of snoring and obstructive sleep apnoea in a Danish population, age 30-60. J Sleep Res 1992;1:240-4. [section 1.1] [section 2.1] [section 4.2]

5 Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994;343:572-5.

6 Smith IE, Shneerson JM. Is the SF 36 sensitive to sleep disruption? A study in subjects with sleep apnoea. J Sleep Res 1995;4:183-8.

7 Cartwright RD, Knight S. Silent partners: the wives of sleep apneic patients. Sleep 1987;10:244-8.

8 Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. N Engl J Med 1999;340:847-51.

9 George CF, Smiley A. Sleep apnea and automobile crashes. Sleep 1999;22:790-5.

10 Maycock G. Sleepiness and driving: the experience of UK car drivers. J Sleep Res 1996;5:229-37.

11 Horne JA, Reyner LA. Sleep related vehicle accidents. BMJ 1995;310:565-7. [section 1.1] [section 6.3]

12 Horstmann S, Hess CW, Bassetti C, Gugger M, Mathis J. Sleepiness-related accidents in sleep apnea patients. Sleep 2000;23:383-9.

13 Department of the Environment, Transport and the Regions. 1999 valuation of the benefits of prevention of road accidents and casualties. London: The Department; 2000. Highways economics note No. 1. [cited 28 Apr 2003]. Available from url: http://www.dft.gov.uk/stellent/groups/dft_rdsafety/documents/page/dft_rdsafety_504571-01.hcsp

14 Ancoli-Israel S, Kripke DF, Mason W, Kaplan OJ. Sleep apnea and periodic movements in an aging sample. J Gerontol 1985;40:419-25.

15 Mather R, Mortimore IL, Jan MA, Douglas NJ. Effect of breathing, pressure and posture on palatoglossal and genioglossal tone. Clin Sci 1995;89:441-5.

16 Redline S, Tishler PV, Tosteson TD, Williamson J, Kump K, Browner I, et al. The familial aggregation of obstructive sleep apnea. Am J Respir Crit Care Med 1995;151:682-7.

17 Motta J, Guilleminault C, Schroeder JS, Dement WC. Tracheostomy and hemodynamic changes in sleep-inducing apnea. Ann Intern Med 1978; 89:454-8.

18 Carlson JT, Hedner JA, Ejnell H, Peterson LE. High prevalence of hypertension in sleep apnea patients independent of obesity. Am J Respir Crit Care Med 1994;150:72-7.

19 Worsnop CJ, Naughton MT, Barter CE, Morgan TO, Anderson AI, Pierce RJ. The prevalence of obstructive sleep apnea in hypertensives. Am J Respir Crit Care Med 1998;157:111-5.

20 Davies CW, Crosby JH, Mullins RL, Barbour C, Davies RJ, Stradling JR. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 2000;55:726-8.

21 Olson LG, King MT, Hensley MJ, Saunders NA. A community study of snoring and sleep-disordered breathing. Health outcomes. Am J Respir Crit Care Med 1995;152:717-20.

22 Hla KM,Young TB, Bidwell T, Palta M, Skatrud JB, Dempsey J. Sleep apnea and hypertension. A population based study. Ann Int Med 1994;120:382-8.

23 Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Eng J Med 2000;342:1378-84.

24 Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Leiby BE, Vela-Bueno A, et al. Association of hypertension and sleep-disordered breathing. Arch Inter Med 2000;160:2289-95.

25 Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000;320:479-82.

26 Grote L, Ploch T, Heitmann J, Knaack L, Penzel T, Peter JH. Sleep-related breathing disorder is an independent risk factor for systemic hypertension. Am J Respir Crit Care Med 1999;160:1875-82.

27 Faccenda JF, Mackay TW, Boon NA, Douglas NJ. Randomised placebo-controlled trial of continuous positive airways pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001;163:344-8. [section 2.1.1] [section 3.2]

28 MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke. and coronary heart disease. Part I, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilutional bias. Lancet 1990;335:765-74.

29 Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002;359:204-10. [section 2.1.1] [section 3.2]

30 Bennett LS, Langford BA, Stradling JR, Davies RJ. Sleep fragmentation indices as predictors of daytime sleepiness and nCPAP response in obstructive sleep apnea. Am J Respir Crit Care Med 1998;158:778-86. [section 2.2] [section 3.5.3]

31 Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-9. [section 2.2] [section 3.5.4]

32 Duran J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001;163:685-9.

33 Monasterio C, Vidal S, Duran J, Ferrer M, Carmona C, Barbe F, et al. Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001;164:939-43. [section 2.2] [section 4.1.1]

34 Barnes M, Houston D, Worsnop CJ, Neil AM, Mykytyn IJ, Kay A, et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med 2002;165:773-80. [section 2.2] [section 4.1.1] [section 4.3.1][section 6.4.2]

35 Kushida CA, Efron B, Guilleminault C. A predictive morphometric model for the obstructive sleep apnea syndrome. Ann Inter Med 1997;127:581-7.

36 Flemons WW, Whitelaw WA, Brant R, Remmers JE. Likelihood ratios for a sleep apnea clinical prediction rule. Am J Respir Crit Care Med 1994;150:1279-85.

37 McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999 159:1108-14. [section 3.1] [section 4.3.1]

38 Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5. [section 3.1] [section 3.5.7]

39 Parkes JD, Chen SY, Clift SJ, Dahlitz MJ, Dunn G. The clinical diagnosis of the narcoleptic syndrome. J Sleep Res 1998;7:41-52.

40 Kingshott RN, Engelman HM, Deary IJ, Douglas NJ. Does arousal frequency predict daytime function? Eur Respir J 1998;12:1264-70.

41 Kingshott RN, Sime PJ, Engelman HM, Douglas NJ. Self assessment of daytime sleepiness: patient versus partner. Thorax 1995;50:994-5.

42 Engleman HM, Hirst WS, Douglas NJ. Under reporting of sleepiness and driving impairment in patients with sleep apnoea/hypopnoea syndrome. J Sleep Res 1997;6:272-5.

43 Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986;9:519-24.

44 Mitler MM, Van den Hoed HJ, Carskadon MA, Richardson G, Park R, Guilleminault C, et al. REM sleep episodes during the Multiple Sleep Latency Test in narcoleptic patients. Electroencephalogr Clin Neurophysiol 1979;46:479-81.

45 Aldrich MS, Chervin RD, Malow BA. Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep 1997;20:620-9.

46 Mitler MM, Gujavarty KS, Browman CP. Maintenance of wakefulness test: a polysomnographic technique for evaluation treatment efficacy in patients with excessive somnolence. Electroencephalogr Clin Neurophysiol 1982;53:658-61.

47 Mitller MM, Walsleben J, Sangal RB, Hirshkowitz M. Sleep latency on the maintenance of wakefulness test (MWT) for 530 patients with narcolepsy while free of psychoactive drugs. Electroencephalogr Clin Neurophysiol 1998;107:33-8.

48 Bennett LS, Stradling JR, Davies RJ. A behavioural test to assess daytime sleepiness in obstructive sleep apnoea. J Sleep Res 1997;6:142-5.

49 Whittle AT, Finch SP, Mortimore IL, MacKay TW, Douglas NJ. Use of home sleep studies for the diagnosis of the sleep apnoea/hypopnoea syndrome. Thorax 1997;52:1068-73. [section 3.5.2] [section 3.5.3]

50 Bradley PA, Mortimore IL, Douglas NJ. Comparison of polysomnography with ResCare Autoset in the diagnosis of the sleep apnoea/hypopnoea syndrome. Thorax 1995;50:1201-3. [section 3.5.2] [section 3.5.3]

51 Stradling J, Davies RJ. Is it necessary to record sleep? Sleep 1996;19:S251-4.

52 Chesson AL Jr, Ferber RA, Fry JM, Grigg-Damberger M, Hartse KM, Hurwitz TD, et al. The indications for polysomnography and related procedures. Sleep 1997;20:423-87.

53 Douglas NJ, Thomas S, Jan MA. Clinical value of polysomnography. Lancet 1992;339:347-50. [section 3.5.2] [section 3.5.4]

54 Rees K, Wraith PK, Berthon-Jones M, Douglas NJ. Detection of apnoeas, hypopnoeas and arousals by the Autoset in the sleep apnoea/hypopnoea syndrome. Eur Respir J 1998;12:764-9.

55 Engleman HM, McDonald JP, Graham D, Lello G, Kingshott RN, Coleman EL, et al. Randomized crossover trial of two treatments for the sleep apnea/hypopnea syndrome: continuous positive airway pressure and mandibular repositioning splint. Am J Respir Critl Care Med 2002;166:855-9. [section 3.5.3] [section 4.3.4]

56 Carrasco O, Montserrat JM, Lloberes P, Ascasco C, Ballester E, Fornas C, et al. Visual and different automatic scoring profiles of respiratory variables in the diagnosis of sleep apnoea-hypopnoea syndrome. Eur Respir J 1996;9:125-30.

57 Garcia Diaz EM, Capote Gil F, Cano Gomez S, Sanchez Armengol A, Carmona Bernal C, Soto Campos JG. Respiratory polygraphy in the diagnosis of obstructive sleep apnea syndrome. Arch Bronconeumol 1997;33:69-73.

58 Lloberes P, Montserrat JM, Ascaso A, Parra O, Granados A, Alonso P, et al. Comparison of partially attended night time respiratory recordings and full polysomnography in patients with suspected sleep apnoea/hypopnoea syndrome. Thorax 1996;51:1043-7.

59 Ross SD, Allen IE, Harrison KJ, Kvasz M, Connelly J, Sheinhait IA. Systematic review of the literature regarding the diagnosis of sleep apnea. Rockville (MD): Agency for Health Care Policy and Research; 1999. AHCPR publication No. 99-E002. [cited 28 Apr 2003]. Available from url: http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat1.chapter.2 [section 3.5.3] [section 3.5.4] [section 3.6]

60 Krieger J, Sforza E, Petiau C, Weiss T. Simplified diagnostic procedure for obstructive sleep apnoea syndrome: lower subsequent compliance with CPAP. Eur Respir J 1998;12:776-9.

61 Series F, Marc I, Cormier Y, La Forge J. Utility of nocturnal home oximetry for case finding in patients with suspected sleep apnea hypopnea syndrome. Ann Intern Med 1993;119:449-53.

62 Chiner E, Signes-Costa J, Arriero JM, Marco J, Fuentes I, Sergado A. Nocturnal oximetry for the diagnosis of the sleep apnoea hypopnoea syndrome: a method to reduce the number of polysomnographies? Thorax 1999;54:968-71.

63 Vazquez JC, Tsai WH, Flemons WW, Masuda A, Brant R, Hajduk E, et al. Automated analysis of digital oximetry in the diagnosis of obstructive sleep apneoa. Thorax 2000;55:302-7.

64 Ryan PJ, Hilton MF, Boldy DA, Evans A, Bradbury S, Sapiano S, et al. Validation of British Thoracic Society guidelines for the diagnosis of the sleep aspnoea/hypopnoea syndrome: can polysomnography be avoided? Thorax 1995;50:972-5.

65 Riley R, Guilleminault C, Herran J, Powell N. Cephalometric analyses and flow volume loops in obstructive sleep apnea patients. Sleep 1983;6:303-11.

66 Haponik EF, Smith PL, Bohlman ME, Allen RP, Goldman SM, Bleecker ER. Computerized tomography in obstructive sleep apnea. Correlation of airway size with physiology during sleep and wakefulness. Am Rev Respir Dis 1983;27;221-6.

67 Rivlin J, Hoffstein V, Kalbfleisch J, McNicholas W, Zamel N, Bryan AC. Upper airway morphology in patients with idiopathic obstructive sleep apnea. Am Rev Respir Dis 1984;129:355-60.

68 Martin SE, Marshall I, Douglas NJ. The effect of posture on airway caliber with the sleep-apnea/hypopnea syndrome. Am J Respir Crit Care Med 1995;152:721-4.

69 Rodenstein DO, Dooms G, Thomas Y, Liistro G, Stanescu DC, Culee C, et al. Pharyngeal shape and dimensions in healthy subjects, snorers, and patients with obstructive sleep apnoea. Thorax 1990;45:722-7.

70 Shelton KE, Woodson H, Gay S, Suratt PM. Pharyngeal fat in obstructive sleep apnea. Am Rev Respir Dis 1993;148:462-6. [section 3.5.6] [section 3.5.7]

71 Pouliot Z, Peters M, Neufeld H, Kryger MH. Using self-reported questionnaire data to prioritize OSA patients for polysomnography. Sleep 1997;20:232-6.

72 Royal College of Physicians of London. Sleep apnoea and related conditions: with recommendations for service provision. London: The College; 1993.

73 National Health and Medical Research Council. Effectiveness of nasal continuous positive airway pressure (nCPAP) in obstructive sleep apnoea in adults. Canberra: The Council; 2000. [cited 28 Apr 2003]. Available from url: http://www.health.gov.au/nhmrc/publications/pdf/hpr21.pdf [section 4.1.1] [section 4.3.1] [section 6.3] [section 6.4] [section 6.4.1] [section 6.4.2]

74 Jenkinson C, Davies RJ, Mullins R, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999;353:2100-5. [section 4.1.1] [section 4.3.1] [section 6.4.2]

75 Hack M, Davies RJ, Mullins R, Choi SJ, Ramdassingh-Dow S, Jenkinson C, et al. Randomised prospective parallel trial of therapeutic versus subtherapeutic nasal continuous positive airways pressure on simulated steering performance in patients with obstructive sleep apnoea. Thorax 2000;55:224-31. [section 4.1.1] [section 6.3]

76 Barbe F, Mayoralas LR, Duran J, Masa JF, Maimo A, Monsarrat JM, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. A randomized, controlled trial. Ann Intern Med 2001;134:1015-23. [section 4.1.1] [section 4.3.1]

77 Hoy CJ, Vennelle M, Kingshott RN, Engleman HM, Douglas NJ. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome? Am J Respir Crit Care Med 1999;159:1096-100.

78 Harvey EL, Glenny A-M, Kirk SFL, Summerbell CD. Improving health professionals’ management and the organisation of care for overweight and obese people (Cochrane Review). In: The Cochrane Library, Issue 1, 2002. Oxford: Update Software.

79 Smith PL, Gold AR, Meyers DA, Haponik EF, Bleecker ER. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985;103:850-5.

80 Dhabuwala A, Cannan RJ, Stubbs RS. Improvement in co-morbidities following weight loss from gastric bypass surgery. Obes Surg 2000;10:428-35.

81 Pillar G, Peled R, Lavie P. Recurrence of sleep apnea without concomitant weight increase 7.5 years after weight reduction surgery. Chest 1994;106:1702-4.

82 Shneerson J, Wright J. Lifestyle modification for obstructive sleep apnoea (Cochrane Review). In: The Cochrane Library, Issue 1, 2002. Oxford: Update Software.

83 Wright J, White J, Ducharme F. Continuous positive airways pressure for obstructive sleep apnoea (Cochrane Review). In: The Cochrane Library, Issue 1, 2002. Oxford: Update Software. [section 4.3.1] [section 4.3.4] [section 6.3] [section 6.4] [section 6.4.2]

84 Haraldsson PO, Carenfelt C, Knutsson E, Persson HE, Rinder J. Preliminary report: validity of symptom analysis and daytime polysomnography in diagnosis of sleep apnea. Sleep 1992;15:261-3.

85 Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ. Randomised placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159:461-7. [section 4.3.1] [section 6.4.2]

86 Engelman HM, Martin SE, Deary IJ, Douglas NJ. Effect of CPAP therapy on daytime function in sleep apnoea/hypopnoea syndrome. Thorax 1997;52:114-9. [section 4.3.1] [section 6.4.2]

87 Redline S, Adams N, Strauss ME, Roebuck T, Winters M, Rosenberg C. Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med 1998;157:858-65.

88 Wright J, Johns R, Watt I, Melville A, Sheldon T. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. BMJ 1997;314:851-60. [section 4.3.1] [section 6.3]

89 Ballester E, Badia JR, Hernandez L, Carrasco E, de Pablo J, Fornas C, et al. Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hyponea syndrome. Am J Respir Crit Care Med 1999;159;495-501. [section 4.3.1] [section 6.4.2]

90 Engleman HM, Martin SE, Kingshott RN, Mackay TW, Deary IJ, Douglas NJ. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998;53:341-5.

91 Lloberes P, Ballester E, Montserrat JM, Botifoll E, Ramirez A, Reolid A, et al. Comparison of manual and automatic CPAP titration in patients with sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1996;154:1755-8.

92 Teschler H, Berthon-Jones M, Thompson AB, Henkel A, Henry J, Konietzko N. Automated continuous positive airway pressure titration for obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996;154:734-40.

93 Massie CA, Hart RW, Peralez K, Richards GN. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest 1999;116:403-8.

94 Meurice JC, Marc I, Series F. Efficacy of auto-CPAP in the treatment of obstructive sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1996;153:794-8.

95 Engleman HM, Asgari-Jirhandeh N, McLeod AL, Ramsay CF, Deary IJ, Douglas NJ. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 1996;109:1470-6.

96 Richards GN, Cistulli PA, Ungar RG, Berthon-Jones M, Sullivan CE. Mouth leak with nasal continuous positive airway pressure increases nasal airway resistance. Am J Respir Crit Care Med 1996;154:182-6.

97 Chervin RD, Theut S, Bassetti C, Aldrich MS. Compliance with nasal CPAP can be improved by simple interventions. Sleep 1997;20:284-9.

98 McArdle N, Grove A, Devereux G, Mackay-Brown L, Mackay T, Douglas NJ. Split-night versus full-night studies for sleep apnoea/hypopnoea syndrome. Eur Respir J 2000;15:670-5.

99 Weaver TE, Kribbs NB, Pack AI, Kline LR, Chugh DK, Maislin G, et al. Night-to-night variability in CPAP use over the first three months of treatment. Sleep 1997;20:278-83.

100 Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993;147:887-95.

101 Kapur V, Blough DK, Sandblom RE, Hert R, de Maine JB, Sullivan SD, et al. The medical cost of undiagnosed sleep apnea. Sleep 1999;22:749-55.

102 Peker Y, Hedner J, Johansson A, Bende M. Reduced hospitalization with cardiovascular and pulmonary disease in obstructive sleep apnea patients on nasal CPAP treatment. Sleep 1997;20:645-53.

103 Krieger J, Meslier N, Lebrun T, Levy P, Phillip-Joet F, Sailly JC, et al. Accidents in obstructive sleep apnea patients treated with nasal continuous positive airway pressure: a prospective study. The Working Group ANTADIR, Paris and CRESGE, Lille, France. Association Nationale de Traitement a Domicile des Insuffisants Respiratoires. Chest 1997;112:1561-6.

104 George CF. Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP. Thorax 2001;56:508-12. [section 4.3.2] [section 6.4.2]

105 Douglas NJ, George CF. Treating sleep apnoea is cost effective. Thorax 2002;57:93.

106 Bahammam A, Delaive K, Ronald J, Manfreda J, Roos L, Kryger MH. Health care utilization in males with obstructive sleep apnea syndrome two years after diagnosis and treatment. Sleep 1999;22:740-7.

107 Tousignant P, Cosio MG, Levy RD, Groome PA. Quality adjusted life years added by treatment of obstructive sleep apnea. Sleep 1994;17:52-60.

108 Chilcott J, Clayton E, Chada N, Hanning CD, Kinnear W, Waterhouse JC. Nasal continuous positive airways pressure in the management of sleep apnoea. Sheffield: Trent Institute for Health Services Research; 2000. Guidance note for purchasers: 00/06.

109 Reeves-Hoche MK, Hudgel DW, Merk R, Witteman AR, Ross A, Zwillich CW. Continuous versus bilevel positive airway pressure for obstructive sleep apnea. Am J Respir Crit Care 1995;151;443-9.

110 British Thoracic Society Standards of Care Committee. Non-invasive ventilation in acute respiratory failure. Thorax 2002;57:192-211.

111 O’Sullivan RA, Hillman DR, Mateljan R, Pantin C, Finucane KE. Mandibular advancement splint: an appliance to treat snoring and obstructive sleep apnea. Am J Respir Crit Care Med 1995;151:194-8.

112 Neill A, Whyman R, Bannan S, Jeffrey O, Campbell A. Mandibular advancement splint improves indices of obstructive sleep apnoea and snoring but side effects are common. N Z Med J 2002;115:289-92.

113 Johnston CD, Gleadhill IC, Cinnamond MJ, Gabbey J, Burden DJ. Mandibular advancement appliances and obstructive sleep apnoea: a randomized clinical trial. Eur J Orthod 2002;24:251-62.

114 Johnston CD, Gleadhill IC, Cinnamond MJ, Peden WM. Oral appliances for the management of severe snoring: a randomized controlled trial. Eur J Orthod 2001;23:127-34.

115 Mehta A, Qian J, Petocz P, Darendeliler MA, Cistulli PA. A randomized, controlled study of a mandibular advancement splint for obstructive sleep apnea. Am J Respir Crit Care Med 2001;163:1457-61.

116 Gotsopoulos H, Chen C, Qian J, Cistulli PA. Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial. Am J Respir Crit Care Med 2002;166:743-8.

117 Bloch KE, Iseli A, Zhang JN, Xie X, Kaplan V, Stoeckli PW, et al. A randomixed, controlled crossover trial of two oral appliances for sleep apnea treatment. Am J Respir Crit Care Med 2000;162:246-51. [section 4.3.4] [section 6.5]

118 Ferguson KA, Ono T, Lowe AA, Keenan SP, Fleetham JA. A randomized crossover study of an oral appliance vs nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest 1996;109:1269-75. [section 4.3.4] [section 6.5]

119 Ferguson KA, Ono T, Lowe AA, al Majed S, Love LL, Fleetham JA. A short-term controlled trial of an adjustable oral appliance for the treatment of mild to moderate obstructive sleep apnoea. Thorax 1997;52:362-8. [section 4.3.4] [section 6.5]

120 Engleman HM, McDonald JP, Graham D, Lello GE, Kingshott RN, Coleman EL, et al. Randomized crossover trial of two treatments for sleep apnea/hypopnea syndrome: continuous positive airway pressure and mandibular repositioning splint. Am J Respir Crit Care Med 2002;166:855-9.

121 Tan YK, L’Estrange PR, Luo YM, Smith C, Grant HR, Simonds AK, et al. Mandibular advancement splints and continuous positive airway pressure in patients with obstructive sleep apnoea: a randomized cross-over trial. Eur J Orthod 2002;24:239-49.

122 Clark GT, Blumenfeld I, Yoffe N, Peled E, Lavie P. A crossover study comparing the efficacy of continuous positive airway pressure with anterior mandibular positioning devices on patients with obstructive sleep apnea. Chest 1996;109:1477-83.

123 Walker-Engstrom ML, Tegelberg A, Wilhelmsson B, Ringqvist I. 4-year follow-up of treatment with dental appliance or uvulopalatopharyngoplasty in patients with obstructive sleep apnea: a randomized study. Chest 2002;121:739-46.

124 Stradling JR, Negus TW, Smith D, Langford B. Mandibular advancement devices for the control of snoring. Eur Respir J 1998;11:447-50.

125 Pantin CC, Hillman DR, Tennant M. Dental side effects of an oral device to treat snoring and obstructive sleep apnea. Sleep 1999;22:237-40.

126 Fritsch KM, Iseli A, Russi EW, Bloch KE. Side effects of mandibular advancement devices for sleep apnoea treatment. Am J Respir Crit Care Med 2001;164:813-8.

127 Rose EC, Staats R, Virchow C, Jonas IE. Occlusional and skeletal effects of an oral appliance in the treatment of obstructive sleep apnoea. Chest 2002;122:871-7.

128 Smith I, Lasserson T, Wright J. Drug treatments for obstructive sleep apnoea (Cochrane Review). In: The Cochrane Library, Issue 1, 2002. Oxford: Update Software.

129 Hudgel DW, Thanakitcharu S. Pharmacologic treatment of sleep-disordered breathing. Am J Respir Crit Care Med 1998;158:691-9.

130 Kingshott RN, Vennelle M, Coleman EL, Engleman HM, Mackay TW, Douglas NJ. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 2001;163:918-23.

131 Sher AE, Schechtman KB, Piccirillo JF. The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep 1996;19:156-77.

132 Bridgman SA, Dunn KM, Ducharme F. Surgery for obstructive sleep apnoea (Cochrane Review). In: The Cochrane Library, Issue 1, 2002. Oxford: Update Software. [section 5.2.1] [section 6.6]

133 Verse T, Pirsig W. Meta-analysis of laser-assisted uvulopalatopharyngoplasty. What is clinically relevant up to now?. Laryngorhinootologie 2000;79:273-84.

134 Verse T, Kroker BA, Pirsig W, Brosch S. Tonsillectomy as a treatment of obstructive sleep apnea in adults with tonsillar hypertrophy. Laryngoscope 2000;110:1556-9.

135 Boot H, van Wegen R, Poublon RM, Bogaard JM, Schmitz PI, van der Meche FG. Long-term results of uvulopalatopharyngoplasty for obstructive sleep apnea syndrome. Laryngoscope 2000;110:469-75.

136 Aboussouan LS, Golish JA, Wood BG, Mehta AC, Wood DE, Dinner DS. Dynamic pharyngoscopy in predicting outcome of uvulopalatopharyngoplasty for moderate and severe obstructive sleep apnea. Chest 1995;107:946-51.

137 Lojander J, Maasilta P, Partinen M, Brander PE, Salmi T, Lehtonen H. Nasal-CPAP, surgery, and conservative management for treatment of obstructive sleep apnea syndrome. A randomized study. Chest 1996;110:114-9.

138 Wilhelmsson B, Tegelberg A, Walker-Engstrom ML, Ringqvist M, Andersson L, Krekmanov L, et al. A prospective randomized study of a dental appliance compared with uvulopalatopharyngoplasty in the treatment of obstructive sleep apnoea. Acta Otolaryngol 1999;119:503-9.

139 Haavisto L, Suonpaa J. Complications of uvulopalatopharyngoplasty. Clin Otolaryngol 1994;19:243-7.

140 Sajkov D, Marshall R, Walker P, Mykytyn I, McEvoy RD, Wale J, et al. Sleep apnoea related hypoxia is associated with cognitive disturbances in patients with tetraplegia. Spinal Cord 1998;36:231-9.

141 Ulnick KM, Debo RF. Postoperative treatment of the patient with obstructive sleep apnoea. Otolalaryngol Head Neck Surg 2000;122:233-6.

142 Brosch S, Matthes C, Pirsig W, Verse T. Uvulopalatopharyngoplasty changes fundamental frequency of the voice - a prospective study. J Laryngol Otol 2000;114:113-8.

143 Woodhead CJ, Davies JE, Allen MB. Obstructive sleep apnoea in adults presenting with snoring. Clin Otolarygol 1991;16:401-5.

144 Mortimore IL, Bradley PA, Murray JA, Douglas NJ. Uvulopalatopharyngoplasty may compromise nasal CPAP therapy in sleep apnea syndrome. Am J Respir Crit Care Med 1996;154:1759-62.

145 Janson C, Noges E, Svedberg-Randt S, Lindberg E. What characterizes patients who are unable to tolerate continuous positive airway pressure (CPAP) treatment? Respir Med 2000;94:145-9.

146 Miljeteig H, Mateika S, Haight JS, Cole P, Hoffstein V. Subjective and objective assessment of uvulopalatopharyngoplasty for treatment of snoring and obstructive sleep apnea. Am J Respir Crit Care Med 1994;150:1286-90.

147 Conradt R, Hochban W, Brandenburg U, Heitmann J, Peter JH. Long-term follow-up after surgical treatment of obstructive sleep apnoea by maxillomandibular advancement. Eur Respir J 1997;10:123-8.

148 Sher AE. Update on upper airway surgery for obstructive sleep apnea. Curr Opin Pulm Med 1995;1:504-11.

149 Charuzi I, Lavie P, Peiser J, Peled R. Bariatric surgery in morbidly obese sleep-apnea patients: short- and long-term follow-up. Am J Clin Nutr 1992;55:594S-6S.

150 Friedman M, Tanyeri H, Lim JW, Landsberg R, Vaidyanathan K, Caldarelli D. Effect of improved nasal breathing on obstructive sleep apnea. Otolaryngol Head Neck Surg 2000;122:71-4.

151 Pepin JL, Veale D, Mayer P, Bettega G, Wuyam B, Levy P. Critical analysis of the results of surgery in the treatment of snoring, upper airway resistance syndrome (UARS), and obstructive sleep apnoea (OSA). Sleep 1996;19:S90-100.

152 Loadsman JA, Hillman DR. Anaesthesia and sleep apnoea. Br J Anaesth 2001;86:254-66.

153 Hiremath AS, Hillman DR, James AL, Noffsinger WJ, Platt PR, Singer SL. Relationship between difficult tracheal intubation and obstructive sleep apnoea. Br J Anaesth 1998;80:606-11.

154 Drivers Medical Unit. At a glance. Guide to the current medical standards of fitness to drive. Revised. Swansea: Driver and Vehicle Licensing Agency; 2002.

155 George CF. Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP. Thorax 2001;56:508-12.

156 McCartt AT, Ribner SA, Pack AI, Hammer MC. The scope and nature of the drowsy driving problem in New York State. Accid Anal Prev 1996;28:511-7.

157 Stoohs RA, Bingham LA, Itoi A, Guilleminault C, Dement WC. Sleep and sleep-disordered breathing in commercial long-haul truck drivers. Chest 1995;107:1275-82.

158 George CF, Boudreau AC, Smiley A. Effects of nasal CPAP on simulated driving performance in patients with obstructive sleep apnoea. Thorax 1997;52:648-53.